Although IHC analysis of ER, PR, and HER2 is widely used in the pathological evaluation of breast tumors, additional molecular signatures involving multiple genes and/or proteins are desperately needed to more accurately classify tumors and guide treatment selection. Here, ESR1 is linked to breast neoplasm.